Opportunities
Search

The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.

This Notice of Funding Opportunity (NOFO) invites a single cooperative agreement application for the Resource Center for the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D). The purpose of CaRe-T1D is to support innovative, discovery and mechanistic research through the study of human cardiovascular (CV) tissue. This research seeks to better understand cardiovascular disease (CVD) in type 1 diabetes, highlight differences compared to type 2 diabetes, and ultimately guide the development of therapies to treat this major cause of morbidity and mortality for individuals with type 1 diabetes. To achieve these goals, the Resource Center will expand the CaRe-T1D biorepository of human CV tissue, further develop the data commons for data sharing and for artificial intelligence (AI) tools, coordinate the research activities of the investigative teams in the CaRe-T1D consortium, and make CaRe-T1D resources accessible to the broader research community. This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standar...

Buyer: OBČINA RADOVLJICA | Notice type: cn-desg | Procedure: open | Contract: services | Deadline: 2026-10-01

Buyer: Agora Zaanstreek | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-10-01

Buyer: Universitair Ziekenhuis Brussel | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-10-01

Buyer: Universitair Medisch Centrum Groningen (UMCG) | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-10-01

Buyer: Sipperec | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-10-01

Buyer: Trafikverket Myndighet | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-01

Buyer: Helsingin kaupunki, kaupunkiympäristön toimiala | Notice type: pin-rtl | Contract: works | Deadline: 2026-10-01

Buyer: WMD Drinkwater NV | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-01

Buyer: Provincie Flevoland | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-01

Buyer: Communauté de Communes Coeur de Beauce | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-01

Buyer: Stichting Amsterdam UMC | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-01

Buyer: Gemeente Amstelveen | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-01

Buyer: Vejdirektoratet | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2026-10-01

Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-01

Buyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-01

This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Both structural and functional aspects, including visualizing dynamic elements are important to development of new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Ultimately, research supported in response to this RFA is to encourage technologies that allow, for example, structures such as hair cells, otoliths, membranes, ions, and vasculature to be viewed in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multi-disciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans and intermediate studies in animals, but not non-mammalian species, may be proposed to develop or advance the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.

This funding opportunity aims to support high risk clinical trials for the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Structural and functional aspects, including visualizing dynamic elements, are important to developing new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Research supported in response to this RFA is expected to significantly advance the ability to visualize auditory and vestibular components, such as hair cells, otoliths, membranes, ions, and vasculature, in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multidisciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans must be proposed to develop,advance, or test the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.

This notice of funding opportunity (NOFO) invites applications from eligible organizations to establish a Data Coordination and Integration Center (DCIC) for the NIH HEAL Initiative. This Center will support the coordination and integration of data from both the HEAL INTERACT program and progressively facilitate broader integration of related musculoskeletal datasets and programs. The Data Coordination and Integration Center will lead efforts for managing and integrating complex pain-associated data types and information from the INTERACT Consortium and progressively related datasets. It will also establish a web-accessible information system and disseminate datasets that can facilitate hypothesis generation and be widely used throughout the research community.

This notice of funding opportunity (NOFO) seeks to establish a course to equip researchers studying drug use, drug misuse, and drug addiction with the skills, knowledge, and practical tools needed to translate their scientific discoveries into impactful real world solutions. The course is envisioned to focus on building capacity in product development, entrepreneurship, and innovation pathways so participants can more effectively move biomedical ideas from early research toward implementation, or commercialization. By combining structured training, mentorship, and hands-on experience, the course is envisioned to accelerate the development of biomedical products that address the complex challenges of drug use, drug misuse, and drug addiction, while fostering an interdisciplinary community of investigators prepared to navigate the scientific, regulatory, and business aspects of this unique research field.

Buyer: Ministerie van Defensie | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2026-10-02

Buyer: Møre og Romsdal Fylkeskommune | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-10-02

Buyer: Rhätische Bahn AG | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2026-10-02

Buyer: Nantes Métropole | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2026-10-02